Members of the ATP binding cassette (ABC) transporter family transport various substrates coupled with hydrolysis of ATP. The human ABC transporter superfamily consists of 49 subtypes, some of which function as drug efflux transporters (ABCB1, ABCC subfamily and ABCG2) or sterol transporters (ABCA1, ABCA7, ABCG1, ABCG5 and ABCG8).
Correlation of Induction of ATP Binding
nocarcinoma established from a 54-year-old female.
10) GI-102 is an undifferentiated carcinoma isolated from a primary ovarian carcinoma.
10) GI-103 is a poorly differentiated carcinoma propagated from ascetic fluid derived from pancreatic adenocarcinoma.
10)
PCR Analysis PCR was conducted with specific primer sets (Table 1) through 1 cycle of 94°C for 30 s, 2 cycles of  94°C for 30 s and 72°C for 2 min, 3 cycles of 94°C for 30 s  and 70°C for 2 min, and 25 cycles of 94°C for 30 s and 68°C for 2 min. The RT-PCR products were separated by electrophoresis on agarose gel. All PCR products from human brain were subcloned and sequenced using a DNA sequencer (CEQ2000XL; Beckman Coulter, Fullerton, CA, U.S.A.).
RESULTS AND DISCUSSION
Tissue Distributions of Human ABCA5-Like Transporters Expression of ABCA5-like transporter mRNAs in human tissues was examined by RT-PCR (Fig. 1) . The mRNA expressions of these transporters exhibited similar distribution patterns, which may be related to the fact that the genomic loci of these transporters are located close together.
3) Strong expression of all the transporter mRNAs was detected in the brain, and the nucleotide sequence of each product was identical with that of the corresponding gene. ABCA5 and ABCA8 showed similar mRNA expression profiles in spleen, testis and ovary. Strong ABCA5 mRNA expression was also detected in liver and pancreas. In addition, strong ABCA6 mRNA expression was detected in lung and liver, and ABCA8 mRNA was detected in lung. Figure 2 shows the expression of human ABCA5-like transporter mRNAs in various human tumors as determined by means of RT-PCR analysis. ABCA6, ABCA7 and ABCA8 mRNAs were not detected in any of the examined tumors, but weak expression of ABCA10 was detected in all of them. ABCA5 mRNA was strongly expressed in GI-112 and GI-102, which are moderately to poorly differentiated colon adenocarcinoma and undifferentiated ovarian carcinoma, respectively. Though normal human ovary also expresses ABCA5 mRNA, as shown in Fig. 1, ABCA5 mRNA was not detected in normal colon, suggesting that its expression was induced in colon tumor. In CX-1, a well differentiated colon adenocarcinoma, ABCA5 mRNA was only faintly expressed. However, the low mRNA content in CX-1 may be partly artifactual, because the b-actin mRNA level was lower than in other samples.
Expression of ABCA5-Like Transporters in Human Tumors
Expression of Human ABCA5 and Drug-Resistance Genes in Human Colon Carcinomas Some ABC transporters play a role in drug resistance; their expression is induced in cancer cells, and they mediate the efflux transport of drugs from the cells. The expression of human ABCA5 in normal colon and colon carcinomas was compared with those of ABC transporters known to be involved in drug resistance, such as ABCB1 (MDR1), ABCC1 (MRP1) and ABCA2. 1, 12) The results shown in Fig. 3 indicate that there RT-PCR analysis was performed with the specific primer sets shown in Table 1 . GI-101, breast carcinoma; LX-1, lung carcinoma; GI-117, lung carcinoma; CX-1, colon adenocarcinoma; GI-112, colon adenocarcinoma; PC3, prostatic adenocarcinoma; GI-102, ovarian carcinoma; GI-103, pancreatic adenocarcinoma.
Fig. 1. Tissue Distributions of mRNA Expression of Human ABCA5-Like Transporters
RT-PCR analysis was performed with the specific primer sets shown in Table 1 . H, heart; B, brain; Pl, placenta; Lu, lung; Li, liver; M, skeletal muscle; K, kidney; Pa, pancreas; Sp, spleen; Th, thymus; Pr, prostate; Te, testis; O, ovary; Si, small intestine; C, colon; L, peripheral blood leukocytes.
are different expression profiles of ABC transporters in CX-1 and GI-112. In GI-112, ABCA5 and ABCB1 mRNAs were predominantly expressed, while ABCC1 and ABCA2 mRNAs were predominantly expressed in CX-1. Since GI-112 is a moderately to poorly differentiated adenocarcinoma and CX-1 is a well-differentiated adenocarcinoma from a primary tumor, the difference in expression profile may be related to the differentiation stages of the tumors. Furthermore, the results suggest that induction of ABCA5 in colon carcinoma is linked with ABCB1 induction. This is the first demonstration that expression of ABCA5 is induced in tumors, and further that it may be linked with ABCB1 induction, and may be correlated with the tumor differentiation state. Since progression of malignancy is associated with dedifferentiation, poorly differentiated carcinoma shows a higher grade of malignancy than well-differentiated carcinoma. The introduction of a c-H-ras-1 oncogene into a poorly differentiated human colon carcinoma cells has been reported to result in significant reduction of ABCB1 mRNA expression and P-glycoprotein-mediated drug resistance in association with acquisition of a more differentiated phenotype. 13) This suggested that the change in the expression profile of ABC transporters might be related to the properties of the tumors in each differentiation stage. One possible function of ABCA5 in tumors would be as a drug efflux transporter, which might result in multi-drug resistance, in association with ABCB1. Another possibility is that ABCA5 transport function is related to tumor differentiation. A study in ABCA5 knockout mice showed decreased plasma levels of thyroid hormones, 5) suggesting a relationship between ABCA5 and thyroid hormones. It is conceivable that ABCA5 transports thyroid hormones directly, or transports compounds that regulate thyroid hormone homeostasis. Thyroxine (T4) enhances the development of colon tumors, 14) and levothyroxine (L-T4) upregulates expression of ABCB1 in human colon carcinoma cells, Caco-2. 15) These findings are consistent with the idea that ABCA5 function is related to the differentiation state of colon tumors.
In conclusion, we have measured the mRNA expression profile of ABCA5-like transporters in human tissues and tumors. Our results indicate that ABCA5 mRNA expression is induced in human colon tumors, and this induction is linked with induction of ABCB1 mRNA expression. It is now important to clarify the function of ABCA5 in order to understand its putative role in tumor differentiation and drug resistance. Vol. 30, No. 6 RT-PCR analysis was performed with the specific primer sets shown in Table 1 . CX-1, well differentiated colon adenocarcinoma; GI-112, poorly differentiated colon adenocarcinoma.
